Table: Chugai Pharm -9-MTH group results (IFRS)

Chugai Pharmaceutical

22/10/2021 09:00

Oct 22 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2021        Sep 30, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              677.49              576.52                     
                   (+17.5 pct)         (+13.3 pct)                  
  Operating          282.84              227.32                     
                   (+24.4 pct)         (+41.3 pct)                  
  Pretax
  Net                204.15              162.43                     
                   (+25.7 pct)         (+38.4 pct)                  
  EPS Basic        124.17 yen           98.84 yen                   
  EPS Diluted      124.09 yen           98.74 yen                   
  Ann Div
  -Q2 Div           30.00 yen           75.00 yen                   
  -Q4 Div                               30.00 yen                   
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T